Über uns
Über uns
Führungsteam
Unsere Verantwortung
Kollaborationen
Unsere Standorte
Technologie
Technologie
Produktion
Publikationen
Pipeline
Newsroom
News
Events
Downloads
Investor Relations
Analysten-Coverage
Finanzberichte
Hauptversammlung
Corporate Governance
Karriere
Werden Sie Teil der RNA people
Ausbildung
DE
Natural mRNA
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
by Sovereign
Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals
by Sovereign
A development, that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
by Sovereign
